Pfizer Inventory 2012-2026 | PFE | MacroTrends

Pfizer Inventory 2012-2026 | PFE

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Pfizer inventory for the quarter ending March 31, 2026 was $11.468B, a 2.16% decline year-over-year.

Pfizer inventory for 2024 was $10.851B, a 6.5% increase from 2023.
Pfizer inventory for 2023 was $10.189B, a 13.45% increase from 2022.
Pfizer inventory for 2022 was $8.981B, a 0.86% decline from 2021.

Pfizer Inventory 2012-2026 | PFE

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Pfizer inventory for 2024 was $10.851B, a 6.5% increase from 2023.
Pfizer inventory for 2023 was $10.189B, a 13.45% increase from 2022.
Pfizer inventory for 2022 was $8.981B, a 0.86% decline from 2021.

Related Stocks
Company Name	Market Cap
Eli Lilly (LLY)	$887.6B
Johnson & Johnson (JNJ)	$574.4B
AbbVie (ABBV)	$367.7B
Roche Holding AG (RHHBY)	$318.8B
Merck (MRK)	$299.9B
Novartis AG (NVS)	$294B
Novo Nordisk (NVO)	$167.5B
Sanofi (SNY)	$114B
Bayer (BAYRY)	$46.2B
Innoviva (INVA)	$1.8B